StockData
Nasus Pharma Ltd logo

Nasus Pharma Ltd (NSRX) income statement

NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.29−0.26 (-10.20%)

Close on Nov 20, 2026Market cap $20.65MP/E –Yield –

See a number that looks wrong?